Neurologist-in-Chief
Neurology
Dr. Scott L. Pomeroy, MD
|
|
Give Review
Scott Pomeroy practices Neurology. He went to medical school at University of Cincinnati College of Medicine. He over the years received 4 awards: "America's Top Doctors", "Boston Magazine", "America's Top Doctors for Cancer" and "Super Doctor". Scott Pomeroy is also published. He has 68 publications published. The lastest publication: "The G protein subunit Gs is a tumor suppressor in Sonic hedgehog-driven medulloblastoma.' He accepts Medicare payments and is registered with Medicare.gov.
Publications
- The G protein α subunit Gαs is a tumor suppressor in Sonic hedgehog-driven medulloblastoma.
- Inactivation of the tumor suppressor WTX in a subset of pediatric tumors.
- A developmental program drives aggressive embryonal brain tumors.
- Medulloblastoma Down Under 2013: a report from the third annual meeting of the International Medulloblastoma Working Group.
- α5-GABAA receptors negatively regulate MYC-amplified medulloblastoma growth.
- Genomic analysis of diffuse pediatric low-grade gliomas identifies recurrent oncogenic truncating rearrangements in the transcription factor MYBL1.
- Clinical Practice Guidelines and Practice Parameters for the Child Neurologist.
- Activation of ?-catenin/TCF targets following loss of the tumor suppressor SNF5.
- A novel syndrome caused by the E410K amino acid substitution in the neuronal ?-tubulin isotype 3.
- Sport-related concussion: time to take notice.
- Medulloblastoma biology in the post-genomic era.
- Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations.
- Sleep dysfunction in long term survivors of craniopharyngioma.
- Epigenetic inactivation of the tumor suppressor BIN1 drives proliferation of SNF5-deficient tumors.
- Pleiotropic effects of miR-183~96~182 converge to regulate cell survival, proliferation and migration in medulloblastoma.
- MicroRNA-182 promotes leptomeningeal spread of non-sonic hedgehog-medulloblastoma.
- Molecular subgroups of medulloblastoma: the current consensus.
- Rapid, reliable, and reproducible molecular sub-grouping of clinical medulloblastoma samples.
- Recent advances in autism spectrum disorders.
- Posterior fossa ependymomas: a tale of two subtypes.
- Long-term clinical outcomes following treatment of childhood craniopharyngioma.
- Neuro-oncology training for the child neurology resident.
- Integrative genomic analysis of medulloblastoma identifies a molecular subgroup that drives poor clinical outcome.
- Predicting relapse in patients with medulloblastoma by integrating evidence from clinical and genomic features.
- UBE4B promotes Hdm2-mediated degradation of the tumor suppressor p53.
- miR-34a confers chemosensitivity through modulation of MAGE-A and p53 in medulloblastoma.
- Neuralized1 causes apoptosis and downregulates Notch target genes in medulloblastoma.
- Growing spectrum and relevance of pediatric neuro-immunology.
- Loss of the tumor suppressor Snf5 leads to aberrant activation of the Hedgehog-Gli pathway.
- Epigenetic antagonism between polycomb and SWI/SNF complexes during oncogenic transformation.
- Human TUBB3 mutations perturb microtubule dynamics, kinesin interactions, and axon guidance.
- Frequent amplification of a chr19q13.41 microRNA polycistron in aggressive primitive neuroectodermal brain tumors.
- Pathologic intracellular signaling in childhood pilocytic astrocytomas.
- Pediatric sleep medicine in 2008: state-of-the-art.
- Loss of the epigenetic tumor suppressor SNF5 leads to cancer without genomic instability.
- Schwann cell proliferation during Wallerian degeneration is not necessary for regeneration and remyelination of the peripheral nerves: axon-dependent removal of newly ...
- Cardiac risk after craniopharyngioma therapy.
- The kinesin KIF1Bbeta acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor.
- Introduction: survivors of childhood cancer: the new face of developmental disabilities.
- Gain of 1q is a potential univariate negative prognostic marker for survival in medulloblastoma.
- Overlay analysis of the oligonucleotide array gene expression profiles and copy number abnormalities as determined by array comparative genomic hybridization in medull...
- Molecular genetics of pediatric central nervous system tumors.
- Transverse myelitis after therapy for primitive neuroectodermal tumors.
- Everyday cognitive function after craniopharyngioma in childhood.
- Inactivation of the Snf5 tumor suppressor stimulates cell cycle progression and cooperates with p53 loss in oncogenic transformation.
- Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.
- Ataxia and shaking in a 2-year-old girl: acute marijuana intoxication presenting as seizure.
- A novel role for extracellular signal-regulated kinase 5 and myocyte enhancer factor 2 in medulloblastoma cell death.
- Diencephalic syndrome: a cause of failure to thrive and a model of partial growth hormone resistance.
- INI1 protein expression distinguishes atypical teratoid/rhabdoid tumor from choroid plexus carcinoma.
- Stereotactic radiotherapy for localized low-grade gliomas in children: final results of a prospective trial.
- Craniopharyngioma therapy: long-term effects on hypothalamic function.
- Intracerebral abscess in children: historical trends at Children's Hospital Boston.
- Neural development and the ontogeny of central nervous system tumors.
- Conserved mechanisms across development and tumorigenesis revealed by a mouse development perspective of human cancers.
- Combining gene expression profiles and clinical parameters for risk stratification in medulloblastomas.
- Pediatric brain tumors.
- Medulloblastoma tumorigenesis diverges from cerebellar granule cell differentiation in patched heterozygous mice.
- Progressive myoclonus in a child with a deep cerebellar mass.
- Marked regression of metastatic pilocytic astrocytoma during treatment with imatinib mesylate (STI-571, Gleevec): a case report and laboratory investigation.
- Neuropsychological functioning after surgery in children treated for brain tumor.
- Application of microarrays to neurological disease.
- A phase I trial of etanidazole and hyperfractionated radiotherapy in children with diffuse brainstem glioma.
- Gene expression-based classification of malignant gliomas correlates better with survival than histological classification.
- Medulloblastomas and primitive neuroectodermal tumors rarely contain polyomavirus DNA sequences.
- High-resolution imaging demonstrates dynein-based vesicular transport of activated Trk receptors.
- Focus on central nervous system neoplasia.
Schools
University Of Cincinnati College Of Medicine
Barnes Hospital Stlouis
Children39s Hospital Boston
St Louis Children39s Hospital
Conditions Treated
- Epilepsy
Doctors Specialties
- Pediatric Neurology
- Pediatrics
- Neurology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- Blue Card PPO
- BlueConnect HMO
- Blue with Managed Care Behavioral Health HMO
- Preferred Blue PPO
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- First Health (Coventry Health Care) PPO
- Choice Care PPO
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- PHP-Physicians Health Plan
- Tufts Health Plans
- Tufts PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- America's Top Doctors
- Boston Magazine
- America's Top Doctors for Cancer
- Super Doctor
Education
-
Washington University - Barnes-Jewish Hospital -
Boston Children's Hospital -
University of Cincinnati College of Medicine
Hospital
-
Boston Children's Hospital -
Brigham and Women's Hospital -
Massachusetts General Hospital -
Dana-Farber Cancer Institute
Drug Facts
| NPI NUMBER | 1235158668 | |
| NPPES Provider LastName | POMEROY | |
| NPPES Provider FirstName | SCOTT | |
| NPPES Provider ZIPCode | 021155724 | |
| NPPES Provider State | MA | |
| Specialty Description | Neurology | |
| Total Claim Count | 51.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1235158668 |
| Last Name Of The Provider | POMEROY |
| First Name Of The Provider | SCOTT |
| View All |
Similar Doctors
|
|
Dr. Joseph B. Martin, MD |
|
|
Dr. Carrie P. Peek, MD |
|
|
Dr. Emily A. Gertsch, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Margaret M. Adler, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Simon E. Laganiere, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Alana E. Kirby, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Gregory J. Allam, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Norberto Alvarez, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Fred H. Hochberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel R. Tarsy, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Sylvia V. Thompson |
|
|
Tomo Tarui, BM
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Junne Kamihara, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eugene Roe, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Peter B. Rosenberger, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Malveeka Sharma, MD |